[Strategies and perspectives for addressing immune checkpoint inhibitor resistance in the era of combination immunotherapy for advanced hepatocellular carcinoma].

Q4 Medicine

Japanese Journal of Gastroenterology Pub Date : 2024-01-01 DOI:10.11405/nisshoshi.121.737

Sadahisa Ogasawara, Naoya Kanogawa, Naoya Kato

引用次数: 0

查看原文本刊更多论文

[晚期肝细胞癌联合免疫疗法时代应对免疫检查点抑制剂耐药性的策略和前景]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Japanese Journal of Gastroenterology Medicine-Gastroenterology

CiteScore

0.20

自引率

0.00%

发文量

期刊介绍： The Journal of Gastroenterology, which is the official publication of the Japanese Society of Gastroenterology, publishes Original Articles (Alimentary Tract/Liver, Pancreas, and Biliary Tract), Review Articles, Letters to the Editors and other articles on all aspects of the field of gastroenterology. Significant contributions relating to basic research, theory, and practice are welcomed. These publications are designed to disseminate knowledge in this field to a worldwide audience, and accordingly, its editorial board has an international membership.